FDA Issues Draft Guidance to Accelerate Gene Therapy Development
The U.S. Food and Drug Administration (FDA) has released draft guidance aimed at speeding up the development of gene and cell therapies by leveraging existing scientific and regulatory frameworks, potentially benefiting developers in this sector.
Topics: cell therapy drug development gene therapy